International Journal Of Medical And Pharmaceutical Research • pp. 1-10
NANOTECHNOLOGY BASED DRUG DELIVERY SYSTEMS FOR EFFECTIVE CANCER TREATMENT
Abstract
Cancer remains one of the most significant challenges in modern medical science, creating a continuous need for
safer, more effective, and targeted treatment approaches. Conventional cancer treatments, including chemotherapy
and radiotherapy, are widely used but may cause serious side effects because therapeutic drugs can also affect
healthy cells and tissues. Nanotechnology-based drug delivery systems have emerged as an advanced approach to
improving cancer treatment by transporting therapeutic agents through specially designed nanoscale carriers.
These systems include liposomes, polymeric nanoparticles, dendrimers, lipid-based nanoparticles, metallic
nanoparticles, and other advanced nanocarriers. They can improve drug solubility, stability, circulation time, and
targeted delivery while supporting controlled drug release at specific tumor sites. Nanotechnology also provides
opportunities for combining chemotherapy, gene therapy, immunotherapy, and diagnostic procedures within
advanced therapeutic platforms. Recent research highlights the potential of smart nanocarriers that respond to
biological conditions such as temperature, pH, and enzyme activity. However, challenges related to toxicity,
biocompatibility, manufacturing costs, tumor penetration, and clinical approval remain important concerns. This
research examines the applications, advantages, limitations, and future possibilities of nanotechnology-based drug
delivery systems in cancer treatment. The study emphasizes that continued scientific research, clinical evaluation,
and technological development are essential for improving the safety and effectiveness of nanomedicine and
supporting more personalized cancer treatment approaches.
Record
- Identifier
- https://doi-services.com/1140/228
- Published
- 2026-09-08
- Version
- 1